feed,title,long_url,short_url
Benzinga,Amgen's Otezla Meets Primary Goal In Late-Stage Genital Psoriasis Study,https://benzinga.com/general/biotech/21/12/24399727/amgens-otezla-meets-primary-goal-in-late-stage-genital-psoriasis-study,https://j.mp/3odYfBA
Benzinga,Vir Biotech - GSK's COVID-19 Antibody Shows Preclinical Activity Against Omicron Variant,https://benzinga.com/general/biotech/21/12/24399443/vir-biotech-gsks-covid-19-antibody-shows-preclinical-activity-against-omicron-variant,https://j.mp/31jjOYy
